Cart
sales@molnova.com
(S)-VU0637120
CAS No. 1175940-86-9
(S)-VU0637120( —— )
Catalog No. M36366 CAS No. 1175940-86-9
(S)-VU0637120 is a selective neuropeptide Y(4)R-mutant antagonist used in the study of metabolic disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 411 | In Stock |
|
| 10MG | 584 | In Stock |
|
| 25MG | 866 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(S)-VU0637120
-
NoteResearch use only, not for human use.
-
Brief Description(S)-VU0637120 is a selective neuropeptide Y(4)R-mutant antagonist used in the study of metabolic disorders.
-
Description(S)-VU0637120 is a selective neuropeptide Y(4)R-mutant antagonist used in the study of metabolic disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1175940-86-9
-
Formula Weight397.47
-
Molecular FormulaC16H19N3O5S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(=O)[C@H]1N(S(C)(=O)=O)CCCC1)C2=NC=3C(=CC4=C(C3)OCCO4)S2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Nafimidone
Nafimidone shows anticonvulsant activity in a rat model of amygdala epilepsy and can be used in the treatment of chronic intractable epilepsy.
-
Bak BH3
This peptide, generated from the BH3 domain of Bak (Flu-BakBH3), has been shown to have high-affinity binding to a surface pocket of the Bcl-XL protein that is required for its death antagonist function.
-
Secretin (28-54), hu...
Secretin (28-54), human, which acts on human secretin receptors, is a 27-amino acid residue C-terminally amidated peptide, .
